Clinical Trial 37017

Los Angeles, CA 90024

Study Summary:

Double-Blind, Placebo Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Qualified Participants Must:

• Have had at least a 1-year history of migraine with or without aura consistent with a diagnosis according to the International Classification of Headache Disorders, 3rd edition, beta version
• Have had migraine onset before age 50
• Have a history of migraines typically lasting between 4 and 72 hours if untreated or treated unsuccessfully and migraine episodes are separated by at least 48 hours of headache pain freedom
• Have a history of 2 to 8 migraine attacks per month with moderate to severe headache pain in each of the previous 3 months

Qualified Participants May Receive:

Free medication, Free evaluations, $100.00 per visit.

View Contact Phone Number

Research Site Profile

View Clinic Profile

Study is Available At:

California Advanced Neurotherapeutics
10850 Wilshire Blvd
suite 1260
Los Angeles, CA 90024
View Clinic Location

If you meet the above criteria and live within 50 miles of this clinic please enter your information below and click "I Am Interested In This Study" to be contacted by the study coordinator.


Click "View Contact Phone Number" to get the clinic's phone number.


If you would like to be contacted by the clinical trial representative and live within 25 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'